Showing results (331-340 of 369) with videos related to
Sort By:
Pageof 37
European Urology|March 21, 2014
Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302)Dana E Rathkopf, Matthew R Smith, Johann S de Bono, et al.JAMA Oncology|December 28, 2018
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint BlockadeWassim Abida, Michael L Cheng, Joshua Armenia, et al.European Journal of Cancer (Oxford, England : 1990)|August 16, 2024
Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancerSi-Yang Liu, Tatiana Erazo, Justin Jee, et al.Nature|July 12, 2019
Tumour lineage shapes BRCA-mediated phenotypesPhilip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.Nature|December 12, 2019
Author Correction: Tumour lineage shapes BRCA-mediated phenotypesPhilip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.Cancer Research|January 24, 2012
ARN-509: a novel antiandrogen for prostate cancer treatmentNicola J Clegg, John Wongvipat, James D Joseph, et al.Biorxiv : the Preprint Server for Biology|April 22, 2024
Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted TherapiesSamir Zaidi, Jooyoung Park, Joseph M Chan, et al.Journal of the National Cancer Institute|July 30, 2020
Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic EfficacyKenneth L Pitter, Dana L Casey, Yue C Lu, et al.Proceedings of the National Academy of Sciences of the United States of America|July 5, 2024
Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapiesSamir Zaidi, Jooyoung Park, Joseph M Chan, et al.The New England Journal of Medicine|December 12, 2012
Abiraterone in metastatic prostate cancer without previous chemotherapyCharles J Ryan, Matthew R Smith, Johann S de Bono, et al.Pageof 37